Enzyme (@enzymefinance): AN UPDATE ON MLN

AN UPDATE ON MLN Earlier last week, Binance announced the upcoming delisting of MLN. Enzyme was neither informed ahead of the announcement nor provided with a precise reason for the decision, similarly to when MLN was added to the monitoring list, preventing us from sharing further details with the community. As delisting decisions can involve many factors and in the absence of further explanations, we want to clarify that this decision is not related to operational concerns regarding Enzyme. While we are naturally disappointed by the outcome, MLN remains listed on several major centralized exchanges. Most importantly, Enzyme is stronger today than at any point in its 9-year history. Since the launch of Onyx in Q4 2025, more than 10 asset managers have adopted our tokenized fund infrastructure, powering products ranging from tokenized hedge funds and gold trackers to private credit and money market funds. Onyx AUT continues to grow and now exceeds the historical protocol, with revenues tracking at ATH. Our pipeline also keeps expanding despite difficult market conditions, marking a clear contrast with previous bear markets that pushed much of the industry into standby mode. April marked the strongest month in Enzyme’s history, and momentum continues to build. Cross-chain deposits, synchronous subscriptions, NAV automation, integrations with Octav and 1Token, as well as upcoming extensions to Canton and Rayls are only a few examples of what we have achieved recently. We remain deeply committed to pushing this industry forward and helping establish decentralized infrastructure as the backbone of next-generation financial markets.